Metformin was first used to treat type 2 diabetes in the late 1950s and in 2022 remains the
first-choice drug used daily by approximately 150 million people. An accumulation of …

Objective This document purpose is to create an evidence-based position statement on the
role of metformin therapy in pregnancy complicated by obesity, gestational diabetes (GDM) …

Diabetic osteoporosis (DOP) belongs to secondary osteoporosis caused by diabetes; it has
the characteristics of high morbidity and high disability. In the present study, we constructed …

Objective This study aimed to evaluate maternal serum levels of folate, vitamin B12, and
their ratio on admission for labor and determine whether an imbalance between folate and …

During the last decades, gestational diabetes mellitus (GDM) prevalence has been on the
rise. While insulin remains the gold standard treatment for GDM, metformin use during …

Metformin, the most commonly prescribed drug for the treatment of diabetes, is increasingly
used during pregnancy to address various disorders such as diabetes, obesity …

Maternal obesity is a global problem that increases the risk of short‐and long‐term adverse
outcomes for mother and child, many of which are linked to gestational diabetes mellitus …

Introduction Existing evidence suggests an association between certain vitamins and
metabolic syndrome (MetS), but few epidemiological studies have focused on the effects of …

Background: Gestational diabetes mellitus (GDM) may lead to many adverse effects on
women and their offspring. Method: 24,429 pregnant women were enrolled during early …

Background: Type 2 diabetes mellitus is one of the most globally common chronic diseases.
Metformin is the most popular prescribed medication for the treatment of diabetes. Studies …